title: Climbazole boosts activity of retinoids in skin.
abstract: OBJECTIVE
  To explore whether climbazole enhances retinoid-associated biological activities in vitro and in vivo.
  
  
  METHODS
  Primary human dermal fibroblasts (HDFs) were treated from six to 48 h with either retinoids (retinol, retinyl propionate, retinyl palmitate) alone or in combination with climbazole, and then assessed for cellular retinoic acid-binding protein 2 (CRABP2) mRNA expression by RT-qPCR. Next, skin equivalent (SE) cultures were topically treated with retinol or retinyl propionate, with or without climbazole, and then measured for biological changes in retinoid biomarkers. Lastly, an IRB-approved clinical study was conducted on the outer forearm of 16 subjects to ascertain the effects of low (0.02%) or high (0.1%) levels of retinol, retinyl propionate (0.5%), climbazole (0.5%) or a combination of retinol (0.02%)/climbazole (0.5%). Indicators of retinoid activities were measured after 3 weeks.
  
  
  RESULTS
  Treatment of HDFs with retinol or retinyl propionate was unaffected by climbazole but alone, resulted in a significantly (P < 0.01) higher sustained CRABP2 mRNA expression than those treated with retinyl palmitate or vehicle control. In SEs, climbazole combined with either retinol or retinyl propionate boosted retinoid related activity greater than the retinoid only, reflected by a dose-response, downregulation of loricrin (LOR) and induction of keratin 4 (KRT4) proteins. In vivo, retinol (0.1%) and retinyl propionate (0.5%) significantly increased most evaluated biomarkers, as expected. Low-dose retinol or climbazole alone did not increase these biomarkers; however, in combination, significant (P < 0.05) increases in retinoid and ageing biomarkers were detected.
  
  
  CONCLUSIONS
  Climbazole boosted retinoid activity both in the SE model, after a combined topic treatment with either retinol or retinyl propionate, and in vivo, in combination with a low level of retinol. Based upon the evidence presented here, we suggest that the topical skin application of climbazole in combination with retinoids could deliver skin ageing benefits more than a less robust retinoid alone.
authors.affiliation: Unilever R&D, Trumbull, CT, 06611, USA.
authors.forename: J
authors.initials: J
authors.lastname: Adamus
authors.affiliation: Unilever R&D, Trumbull, CT, 06611, USA.
authors.forename: L
authors.initials: L
authors.lastname: Feng
authors.affiliation: Unilever R&D, Trumbull, CT, 06611, USA.
authors.forename: S
authors.initials: S
authors.lastname: Hawkins
authors.affiliation: Unilever R&D, Trumbull, CT, 06611, USA.
authors.forename: K
authors.initials: K
authors.lastname: Kalleberg
authors.affiliation: Unilever R&D, Trumbull, CT, 06611, USA.
authors.forename: J-M
authors.initials: JM
authors.lastname: Lee
mesh_terms: D000328:Adult; D004311:Double-Blind Method; D005260:Female; D006801:Humans; D007093:Imidazoles / Q000494:pharmacology*; D012333:RNA, Messenger / Q000235:genetics; D060888:Real-Time Polymerase Chain Reaction; D018168:Receptors, Retinoic Acid / Q000235:genetics; D012176:Retinoids / Q000494:pharmacology*; D012867:Skin / Q000166:cytology / Q000187:drug effects*
chemical_list: D007093:Imidazoles; D012333:RNA, Messenger; D018168:Receptors, Retinoic Acid; D012176:Retinoids; C082928:retinoic acid binding protein II, cellular; C108286:climbazole
keywords: cell culture; claim substantiation in vivo/in vitro; climbazole; retinol; skin physiology/structure